Gene · 6240
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer. | Oxid Med Cell Longev | 2023 | 36713030 | PubTator, text mining | PubMed |
| The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy. | Asian Pac J Cancer Prev | 2023 | 36708568 | PubTator, text mining | PubMed |
| SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia. | Blood Adv | 2023 | 36689724 | PubTator, text mining | PubMed |
| [Morphological predictors of the efficacy of mitotane therapy in adrenocortical cancer]. | Probl Endokrinol (Mosk) | 2023 | 36689714 | PubTator, text mining | PubMed |
| Deciphering the RRM-RNA recognition code: A computational analysis. | PLoS Comput Biol | 2023 | 36689472 | PubTator, text mining | PubMed |
| Modeling the resilience of urban mobility when exposed to the COVID-19 pandemic: A qualitative system dynamics approach. | Sustain Cities Soc | 2023 | 36683862 | PubTator, text mining | PubMed |
| Reviewing the Potential Links between Viral Infections and TDP-43 Proteinopathies. | Int J Mol Sci | 2023 | 36675095 | PubTator, text mining | PubMed |
| BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. | Mol Cancer Res | 2023 | 36669126 | PubTator, text mining | PubMed |
| CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylation. | Glycobiology | 2023 | 36648436 | PubTator, text mining | PubMed |
| Stem transcriptome screen for selection in wild and cultivated pitahaya (Selenicereus undatus): an epiphytic cactus with edible fruit. | PeerJ | 2023 | 36632141 | PubTator, text mining | PubMed |
| Integrating Phylogenetics With Intron Positions Illuminates the Origin of the Complex Spliceosome. | Mol Biol Evol | 2023 | 36631250 | PubTator, text mining | PubMed |
| Characterization of the gene signature correlated with favorable response to chemoradiotherapy in rectal cancer: A hypothesis-generating study. | Cancer Med | 2023 | 36621808 | PubTator, text mining | PubMed |
| Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study. | Breast | 2023 | 36586272 | PubTator, text mining | PubMed |
| Npl3 functions in mRNP assembly by recruitment of mRNP components to the transcription site and their transfer onto the mRNA. | Nucleic Acids Res | 2023 | 36583366 | PubTator, text mining | PubMed |
| Pab1 acetylation at K131 decreases stress granule formation in Saccharomyces cerevisiae. | J Biol Chem | 2023 | 36572187 | PubTator, text mining | PubMed |
| Barriers and opportunities for gemcitabine in pancreatic cancer therapy. | Am J Physiol Cell Physiol | 2023 | 36571444 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| dATP elevation induces myocardial metabolic remodeling to support improved cardiac function. | J Mol Cell Cardiol | 2023 | 36470336 | PubTator, text mining | PubMed |
| Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma. | Cancer Med | 2023 | 36464833 | PubTator, text mining | PubMed |
| Set1 regulates telomere function via H3K4 methylation-dependent and -independent pathways and calibrates the abundance of telomere maintenance factors. | Mol Biol Cell | 2023 | 36416860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6240/papers?page=18